REFERÊNCIAS:
BANO A, HEPSOMALI P, RABBANI F et al. The possible "calming effect" of subchronic supplementation of a standardised phospholipid carrier-based Melissa officinalis L. extract in healthy adults with emotional distress and poor sleep conditions: results from a prospective, randomised, double-blinded, placebo-controlled clinical trial. Front Pharmacol. 2023; 14: 1250560.
BORTOLETTO CC, CORDEIRO DA SILVA F, SALGUEIRO MCC et al. Evaluation of electromyographic signals in children with bruxism before and after therapy with Melissa officinalis L. - a randomized controlled clinical trial. J Phys Ther Sci. 2016; 28(3): 738-742.
DUTTA T, ANAND U, MITRA SS et al. Phytotherapy for attention deficit hyperactivity disorder (ADHD): a systematic review and meta-analysis. Front Pharmacol. 2022; 13: 827411.
KARA M, SAHIN S, RABBANI F et al. An in vitro analysis of an innovative standardized phospholipid carrier-based Melissa officinalis L. extract as a potential neuromodulator for emotional distress and related conditions. Front Mol Biosci. 2024; 11: 1359177.
KENNEDY DO, WAKE G, SAVELEV S et al. Modulation of mood and cognitive performance following acute administration of single doses of Melissa officinalis (lemon balm) with human CNS nicotinic and muscarinic receptor-binding properties. Neuropsychopharmacology. 2003; 28(10): 1871-1881.
MÜLLER SF, KLEMENT S. A combination of valerian and lemon balm is effective in the treatment of restlessness and dyssomnia in children. Phytomedicine. 2006; 13(6): 383-387.
NASERI M, ARABI MIANROODI R, PAKZAD Z et al. The effect of Melissa officinalis L. extract on learning and memory: Involvement of hippocampal expression of nitric oxide synthase and brain-derived neurotrophic factor in diabetic rats. J Ethnopharmacol. 2021; 276: 114210.
0
Login/Cadastre-se
